Firefly BioWorks Inc (AKA: Elucigel Technologies) Profile last edited on: 9/5/2023
CAGE: 577J7
UEI: CMJ3KE6ZGM19
Business Identifier: Rapid, cost-effective microRNA profiling used in disease diagnosis 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
1 Kendall Square Building 1400w 3rd Floor
Cambridge, MA 02139
Cambridge, MA 02139
| (617) 500-6247 |
| info@fireflybio.com |
| www.fireflybio.com |
Location: Single
Congr. District: 07
County: Middlesex
Congr. District: 07
County: Middlesex
Public Profile
In January 2015, Fire Fly was acquired by AbCam PLC a Cambridge MA based entitiy that produces and distributes research-grade anti-bodies and associated products. Having originally received their SBIR awards as Elucigel Technologies, Firefly BioWorks, Inc. provides an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed biological assays on standard laboratory instrumentation. The companys core technology, Optical Liquid Stamping, was developed in the Chemical Engineering Department at MIT (News - Alert) by Firefly co-founders. The method allows rapid and scalable synthesis of encoded, multi-functional particles for the quantification of biological function. The companys long-term vision is to provide research and clinical scientists with reliable and affordable solutions for the comprehensive monitoring of biological systems. The firm is listed as a spin-out of the MIT Deshpande Center for Technological Innovation.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
10-14Revenue Range
1M-1.5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
10-14Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2012 | 2 | NIH | $1,975,082 | |
| Project Title: Hydrogel Particle-Based Microrna Profiling for Discovery and Cancer Diagnostics | ||||
| 2010 | 1 | NIH | $176,400 | |
| Project Title: Multiplexed Encoded Particle Pcr For Rapid Panel Diagnosis Of Sexually-Transmitte | ||||
Key People / Management
Davide M Marini -- Co-Founder and Chief Executive Officer
Andrea K Bryan -- Director Of Engineering
Roger Dowd -- Director
Daniel Doyle
Tom Kelly -- Director Of Sales
Daniel C Pregibon -- Co-founder, Chief Technology Officer
Conor Rafferty -- Vice President of Research
Rick Ryan -- Director
Isaac B Stoner -- Vice President Of Product Development
Andreas Windemuth -- Chief Information Officer
Andrea K Bryan -- Director Of Engineering
Roger Dowd -- Director
Daniel Doyle
Tom Kelly -- Director Of Sales
Daniel C Pregibon -- Co-founder, Chief Technology Officer
Conor Rafferty -- Vice President of Research
Rick Ryan -- Director
Isaac B Stoner -- Vice President Of Product Development
Andreas Windemuth -- Chief Information Officer
Company News
|
Apr
16
2013
|
Firefly BioWorks Awards $120K in Grants for microRNA Research |
|
May
24
2012
|
Firefly BioWorks nabs $500K grant |
|
Oct
21
2011
|
Backers light up Firefly BioWorks with $2M financing |
